44m
Hosted on MSNTravere takes rare disease kidney drug to FDA despite failed trialTravere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.
Too much sun, too little water, and that too laced with chemicals may be taking a toll on the kidneys of farm workers.
54m
Hosted on MSNCovenant and local kidney foundation to host sessions for medical professionals in late FebruaryCovenant Health in conjunction with the South Plains Kidney Foundation will host two sessions for medical professionals to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results